Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Rabies Immunization in PID
NCT02490956Phase 4Unknown
- Sponsor
- Chulalongkorn University
- Start
- Apr 2015
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rabies virus inactivated antigen, A in rabies, sponsored by Chulalongkorn University. Primary endpoint: Rabies neutralizing antibody titer at 1 year. Status: unknown.
02
Drugs
rabies virus inactivated antigen, A
03
Conditions
rabies
Beyond the preview
Go deeper on NCT02490956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490956.